Abstract
• CVD impacts cancer onset and progression, yet the underlying mechanisms remain unclear. • Cardiac-secreted factors, altered hematopoiesis, and innate immune changes link atherosclerotic CVD to cancer promotion. • Addressing common risk factors, enhancing surveillance, and targeting inflammation in CVD patients may improve cancer outcomes.